Overproduction of IL-2 by Cbl-b deficient CD4+ T cells provides resistance against regulatory T cells-Reference-Cited by-同舟云学术

Overproduction of IL-2 by Cbl-b deficient CD4+ T cells provides resistance against regulatory T cells

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Han SeongJun¹²,Chung Douglas C.¹²,St. Paul Michael¹²,Liu Zhe Qi¹²,Garcia-Batres Carlos¹,Elford Alisha R.¹,Tran Charles W.¹²,Chapatte Laurence¹,Ohashi Pamela S.¹²

Affiliation:

1. Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

2. Department of Immunology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

Funder

Canadian Institutes of Health Research

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1737368

Reference88 articles.

1. Regulatory T Cells and Immune Tolerance

2. FOXP3+ regulatory T cells in the human immune system

3. The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome.

4. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets;Experimental Hematology & Oncology;2024-08-30

2. Unveiling the link between arsenic toxicity and diabetes: an in silico exploration into the role of transcription factors;Toxicological Research;2024-07-18

3. T cell specific deletion of Casitas B lineage lymphoma-b reduces atherosclerosis, but increases plaque T cell infiltration and systemic T cell activation;Frontiers in Immunology;2024-03-04

4. Casitas b cell lymphoma‑B (Cbl-b): A new therapeutic avenue for small-molecule immunotherapy;Bioorganic & Medicinal Chemistry;2024-03

5. PTPN1 is a prognostic biomarker related to cancer immunity and drug sensitivity: from pan-cancer analysis to validation in breast cancer;Frontiers in Immunology;2023-10-23